Infant Care

Infant Care
Care of HIV-exposed infants is of paramount importance in successfully preventing perinatal transmission. HIV-exposed infants take HIV medication as prophylaxis and require special follow-up for the first few months of life until they are confirmed HIV-negative. NCCC can assist you in providing this care.

Advice on treating HIV-exposed newborns

Perinatal HIV specialists are available 24/7 to answer calls about managing the care of a high-risk HIV-exposed infant. Our clinicians are supported by access to the most up-to-date information and literature for care, an expert HIV community at UCSF/SFGH, and a network of experienced practitioners throughout the country who provide co-management and other resources.

Guidance on managing pediatric PEP

The CDC released updated non-occupational PEP guidelines in April, 2016. Regimen selection and dosing information for non-perinatally exposed infants, children, and adolescents (e.g. found needles) can be found in Tables 5 and 6 on pages 31-37 of the guidelines. The NCCC is updating its guidance on management of pediatric PEP outside of the perinatal period to reflect information provided by these updated guidelines. In the meantime, clinicians may continue to call the NCCC for PEP consultation at 888-448-4911.

Infant Care Resources

  • Strategies for the Care of Neonates at Higher Risk of Perinatal HIV Transmission | NCCC Statement
    Open PDF Open PDF | From the National Clinician Consultation Center
  • The High-Risk HIV-Exposed Newborn: Obstetric and Infant Care Implications | NCCC CROI 2014 discussion
    Open PDF Open PDF | From the National Clinician Consultation Center
  • Informed Choice Breastfeeding in a Resource-Rich Setting | NCCC CROI 2012 discussion
    Open PDF Open PDF | From the National Clinician Consultation Center
  • Informed Choice Breastfeeding in a Resource-Rich Setting | NCCC CROI 2012 discussion slides
    Open PDF Open PDF | From the National Clinician Consultation Center

Helpful Links

  • Antiretroviral Management of Newborns with Perinatal HIV Exposure or HIV Infection
    Visit website | From clinicalinfo.hiv.gov
    The Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission and the Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV jointly develop and update guidance on the optimal use of antiretroviral (ARV) agents during the neonatal period to reduce the risk of perinatal HIV transmission to HIV-exposed infants.